Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor

The development of new anticancer drugs is necessary in order deal with the disease and with the drawbacks of currently applied drugs. Epigenetic dysregulations are a central hallmark of cancerogenesis and histone deacetylases (HDACs) emerged as promising anticancer targets. HDAC inhibitors are prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Goehringer, Nils, Peng, Yayi, Nitzsche, Bianca, Biermann, Hannah, Pradhan, Rohan, Schobert, Rainer, Herling, Marco, Höpfner, Michael, Biersack, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704709/
https://www.ncbi.nlm.nih.gov/pubmed/34959719
http://dx.doi.org/10.3390/ph14121319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704709/
https://www.ncbi.nlm.nih.gov/pubmed/34959719
http://dx.doi.org/10.3390/ph14121319

Ejemplares similares